Copyright 2026 All rights reserved.

About bHLBIO

bHLBIO develops the innovative drug for the healthy human life, using our novel CUPID platform
which can monitor in real time the Protein-Protein Interaction (PPI) in living cell.

Management

Sung-Jun HAN

Ph.D. CEO
  • Paris VI Univ. (UPMC, Sorbonne Univ.)Dept.
    of Biochemistry and Molecular Biology ; PhD
  • OPTIPHARM Co., Ltd.
    (KOSDAQ listed company) ; CEO
  • Insol Co., Ltd. ; Head of R&D Center
  • Molecular Devices (of Danaher) Korea ;
    General Manager
  • Konkuk Univ., Seoul, Korea ; Adjunct Professor
  • Institut Pasteur Korea, Drug Biology Group ;
    Team & Group Leader
  • NIDDK / NIH, Molecular Signaling section ;
    Postdoctoral fellow
Zeewon LEE

Ph.D. Head of R&D center
  • Korea Unv. Molecular Genetics, PhD.
  • CUPID system inventor
  • Former : Korea Basic Science Institute;
    Principal Investigator
  • Former : Chungnam National Unv.;
    Adjunct professor
  • Many governmental Grants
    (PI in > 15 M$ grant)
  • More than 70 articles published
Sukkeun Yoon

Ph.D. Senior Advisor
  • Medicinal chemist
  • LG Chem Life Sciences (15 years)
  • Dong-A ST (Senior Researcher)
  • Harvard Univ. (Research Fellow)
  • KMEDIhub (President)
  • Rochester Univ. (Ph.D.)